|
|
22 Inverness Center Parkway
Birmingham, AL 35242 USA
phone:(205) 991-8085
fax:(205) 991-8176
|
|
| Symbol |
AXCA |
| Exchange |
NASDAQ |
| Founded |
1982 |
| Employees |
|
|
|
| www.axcan.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Distributes gastrointestinal (GI) products, primarily in North America and Europe |
|
| Management |
| Ms. Martha Donze, Vice President, Corporate Administration; Mr. Nicholas Franco, Senior Vice President, International Commercial Operations; Mr. Steve Gannon, Senior Vice President and Chief Financial Officer; Alexandre P. LeBeaut, M.D., Senior Vice President and Chief Scientific Officer; Mr. David W. Mims, Executive Vice President and Chief Operating Officer |
| |
|
|
|
|
|
|
|
| Keywords |
| pharmaceutical , gastroenterology, therapeutic, gastrointestinal, caregivers |
|
|
|
| Description |
|
Axcan is a specialty pharmaceutical company involved in the field of gastroenterology. The company markets a broad line of prescription products sod for the treatment of symtoms in a number of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to cycstic fibrosis. |
|
| Technology / Differentiation |
| Axcan Pharma, a leading specialty pharmaceutical company in the field of gastroenterology, was established in 1982 by former Chairman of the Board, Leon F. Gosselin. Since its inception, Axcan has focused on a single specialization on which to build its reputation - gastroenterology. This singular focus has allowed the Company to leverage its resources hence maximizing its effectiveness in building enduring relationships with health authorities and medical practitioners around the globe. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
